COVID-19 research up to 31 January 2020

Added July 16, 2020

Citation: Adhikari SP, Meng S, Wu YJ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 2020 Mar;9(1):29.

What is this? Information on the epidemiological characteristics of SARS-CoV2 and the effects of control measures might help policy makers and others involved in the management of the COVID-19 pandemic.

In this rapid review, the authors searched for studies on the epidemiology, causes, clinical diagnosis, prevention and control of COVID-19. They restricted their search to articles published in English and Chinese and did their most recent search on 31 January 2020. They included 65 studies, covering epidemiology (19 studies), causes (25), clinical manifestation and diagnosis (9), and prevention and control (12).

What was found: At the time of this review, the included studies showed that the virus’ origin was connected to a seafood market in Wuhan, China.

At the time of this review, the included studies showed that common COVID-19 symptoms included fever, cough, fatigue, pneumonia, headache, diarrhea, hemoptysis and dyspnea.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.